These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 20338870

  • 41. 10-Year analysis of adverse event reports to the Food and Drug Administration for phosphodiesterase type-5 inhibitors.
    Lowe G, Costabile RA.
    J Sex Med; 2012 Jan; 9(1):265-70. PubMed ID: 22023666
    [Abstract] [Full Text] [Related]

  • 42. Binding of tritiated sildenafil, tadalafil, or vardenafil to the phosphodiesterase-5 catalytic site displays potency, specificity, heterogeneity, and cGMP stimulation.
    Blount MA, Beasley A, Zoraghi R, Sekhar KR, Bessay EP, Francis SH, Corbin JD.
    Mol Pharmacol; 2004 Jul; 66(1):144-52. PubMed ID: 15213306
    [Abstract] [Full Text] [Related]

  • 43. Accurate mass measurement using Fourier transform ion cyclotron resonance mass spectrometry for structure elucidation of designer drug analogs of tadalafil, vardenafil and sildenafil in herbal and pharmaceutical matrices.
    Gratz SR, Gamble BM, Flurer RA.
    Rapid Commun Mass Spectrom; 2006 Jul; 20(15):2317-27. PubMed ID: 16817245
    [Abstract] [Full Text] [Related]

  • 44. Simultaneous determination of yohimbine, sildenafil, vardenafil and tadalafil in dietary supplements using high-performance liquid chromatography-tandem mass spectrometry.
    Zhang Y, Huang Z, Ding L, Yan H, Wang M, Zhu S.
    J Sep Sci; 2010 Jul; 33(14):2109-14. PubMed ID: 20533336
    [Abstract] [Full Text] [Related]

  • 45. UHPLC for quality evaluation of genuine and illegal medicines containing sildenafil citrate and tadalafil.
    Reis NFA, Silva LFG, Souza MACE, Fialho SL, Souza Moreira CP, Oliveira Andrade MV, Paula WX, Gloria MBA, Pianetti GA, Fernandes C.
    J Chromatogr Sci; 2021 Jan 01; 59(1):30-39. PubMed ID: 33107906
    [Abstract] [Full Text] [Related]

  • 46. Effectiveness of sildenafil citrate (Viagra) and tadalafil (Cialis) on sexual responses in Saudi men with erectile dysfunction in routine clinical practice.
    Ali ST.
    Pak J Pharm Sci; 2008 Jul 01; 21(3):275-81. PubMed ID: 18614424
    [Abstract] [Full Text] [Related]

  • 47. Critical amino acids in phosphodiesterase-5 catalytic site that provide for high-affinity interaction with cyclic guanosine monophosphate and inhibitors.
    Zoraghi R, Francis SH, Corbin JD.
    Biochemistry; 2007 Nov 27; 46(47):13554-63. PubMed ID: 17979301
    [Abstract] [Full Text] [Related]

  • 48. Review of phosphodiesterases in the urogenital system: new directions for therapeutic intervention.
    Montorsi F, Corbin J, Phillips S.
    J Sex Med; 2004 Nov 27; 1(3):322-36. PubMed ID: 16422964
    [Abstract] [Full Text] [Related]

  • 49. [Treatment of erectile dysfunction after radical retropubic prostatectomy with PDE5 inhibitor].
    Jin W, Huang YR.
    Zhonghua Nan Ke Xue; 2005 Sep 27; 11(9):708-12. PubMed ID: 16209216
    [Abstract] [Full Text] [Related]

  • 50. Phosphodiesterase type V inhibitors: Occurrence and fate in wastewater and sewage sludge.
    Nieto A, Peschka M, Borrull F, Pocurull E, Marcé RM, Knepper TP.
    Water Res; 2010 Mar 27; 44(5):1607-15. PubMed ID: 19959201
    [Abstract] [Full Text] [Related]

  • 51. Comparison between counterfeit and authentic medicines: A novel approach using differential scanning calorimetry and hierarchical cluster analysis.
    Dos Santos MK, de Cassia Mariotti K, Kahmann A, Anzanello MJ, Ferrão MF, de Araújo Gomes A, Limberger RP, Ortiz RS.
    J Pharm Biomed Anal; 2019 Mar 20; 166():304-309. PubMed ID: 30685655
    [Abstract] [Full Text] [Related]

  • 52. Tadalafil (Cialis) and vardenafil (Levitra) recently approved drugs for erectile dysfunction.
    Gaines KK.
    Urol Nurs; 2004 Feb 20; 24(1):46-8. PubMed ID: 15054911
    [No Abstract] [Full Text] [Related]

  • 53. Treating erectile dysfunction and central neurological diseases with oral phosphodiesterase type 5 inhibitors. Review of the literature.
    Lombardi G, Nelli F, Celso M, Mencarini M, Del Popolo G.
    J Sex Med; 2012 Apr 20; 9(4):970-85. PubMed ID: 22304626
    [Abstract] [Full Text] [Related]

  • 54. Cardiovascular protection with sildenafil following chronic inhibition of nitric oxide synthase.
    Kukreja RC.
    Br J Pharmacol; 2007 Mar 20; 150(5):538-40. PubMed ID: 17245364
    [Abstract] [Full Text] [Related]

  • 55. Qualitative and quantitative analysis of PDE-5 inhibitors in counterfeit medicines and dietary supplements by HPLC-UV using sildenafil as a sole reference.
    Fejős I, Neumajer G, Béni S, Jankovics P.
    J Pharm Biomed Anal; 2014 Sep 20; 98():327-33. PubMed ID: 24996004
    [Abstract] [Full Text] [Related]

  • 56. Physician-rated patient preference and patient- and partner-rated preference for tadalafil or sildenafil citrate: results from the Canadian 'Treatment of Erectile Dysfunction' observational study.
    Lee J, Pommerville P, Brock G, Gagnon R, Mehta P, Krisdaphongs M, Chan M, Chan J, Dickson R.
    BJU Int; 2006 Sep 20; 98(3):623-9. PubMed ID: 16925764
    [Abstract] [Full Text] [Related]

  • 57. Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open-label, crossover study.
    Eardley I, Montorsi F, Jackson G, Mirone V, Chan ML, Loughney K, Vail GM, Beardsworth A.
    BJU Int; 2007 Jul 20; 100(1):122-9. PubMed ID: 17552960
    [Abstract] [Full Text] [Related]

  • 58. Erectile dysfunction diagnosis and treatment as a means to improve medication adherence and optimize comorbidity management.
    Scranton RE, Goldstein I, Stecher VJ.
    J Sex Med; 2013 Feb 20; 10(2):551-61. PubMed ID: 23153075
    [Abstract] [Full Text] [Related]

  • 59. A survey on illegal and counterfeit medicines for the treatment of erectile dysfunctions in Italy.
    Gaudiano MC, Manna L, Rodomonte AL, Bartolomei M, Bertocchi P, Gallinella B, Antoniella E, Muleri N, Civitelli G, Alimonti S, Romanini L, Rufini L, Valvo L.
    J Sex Med; 2012 Aug 20; 9(8):2130-7. PubMed ID: 22612848
    [Abstract] [Full Text] [Related]

  • 60. Phosphodiesterase 5 inhibitors for erectile dysfunction.
    Setter SM, Iltz JL, Fincham JE, Campbell RK, Baker DE.
    Ann Pharmacother; 2005 Aug 20; 39(7-8):1286-95. PubMed ID: 15941818
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.